About Andreu Prados

Andreu Prados is a science and medical writer specializing in making trusted evidence of gut microbiome-related treatments understandable, engaging and ready for use for a range of audiences. He holds bachelor’s degrees in Pharmacy and Human Nutrition and Dietetics and a PhD in nutrition communication. Follow Andreu on Twitter @andreuprados

While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.

Gut fungi have effects beyond the gut through the gut-brain axis

14 Feb 2024

by Rene van den Wijngaard, Andreu Prados

Most research on the role of gut microbiota in the gut-brain axis has focused on bacteria, while fungi living inside the gut have been overlooked. What do we know about the role of gut fungi in the communication between the gut and the brain?

Diets for irritable bowel syndrome: what you need to know

20 Dec 2023

by Andreu Prados, Kate Scarlata

Food is considered the main trigger of digestive symptoms in the vast majority of patients living with IBS. While finding foods that do not prompt gastrointestinal (GI) symptoms has been a challenge for many people with IBS, restrictive diets can come with potential risks. Learn more about diets with evidence in IBS.

Where are we on microbiome-based therapies in disorders of gut-brain interaction?

4 Dec 2023

by Andreu Prados, Rene van den Wijngaard

NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).

NeuroGASTRO 2023, the leading meeting in Europe held by ESNM on the latest developments in neurogastroenterology, digestive motility, and disorders of the gut-brain interaction, took place from August 31st to September 2nd, 2023. Find out more what the latest research says about the involvement of the intestinal microbiota, mast cells, eosinophils and gut barrier in disorders of gut-brain interaction and dietary considerations in their management picked up by GMFH editors (Part 1).

Certainties and uncertainties of SIBO

26 Oct 2023

by Andreu Prados

While SIBO is not new, it has recently gained popularity on the internet and on social media as the result of a set of non-specific symptoms such as abdominal pain, bloating, and even chronic fatigue. In this post, we will discuss what SIBO is and what it is not, its roots, symptoms, diagnosis, and management.

The human microbiome has captured the interest of both scientists and the lay public. A survey of 6,500 people worldwide shows a lack of understanding of the role of the microbiome on health and an essential role of healthcare professionals in promoting advice to balance the microbiome.

The microorganisms that live in and on our body have been implicated in a variety of health functions and diseases. Two microbiologists comment on certain common assumptions about the human microbiota, including that it weighs 2 kg and is altered in case of obesity.

Go to Top